New ‘digital’ pills pose data protection and cybersecurity challenges for drugs manufacturers and health bodies, says expert

The regulatory approval of a new ‘digital pill’ in the US is an exciting development that highlights the potential of connected technologies in health care, an expert in life sciences has said.